Workflow
个体化精准治疗
icon
Search documents
专家:关注早期肺癌患者的个体化精准治疗
Bei Ke Cai Jing· 2025-07-27 13:13
Core Insights - The "2025 Beijing International Thoracic Surgery Academic Conference" focuses on the latest technologies and challenges in thoracic surgery, emphasizing the theme "Empowerment and Long-term Vision" [1] - Lung cancer remains the most prevalent malignant tumor in China, with approximately 1.06 million new cases in 2022, accounting for 22% of all malignant tumors, and it has the highest mortality rate [1] - Early detection, diagnosis, and treatment are crucial for curing early-stage lung cancer patients [1] Group 1 - The diagnosis and treatment of pulmonary nodules and early-stage lung cancer are increasingly emphasized, with a notable concern regarding the 10%-15% recurrence rate in stage IA patients [2] - A retrospective study by the team at Capital Medical University Xuanwu Hospital indicates that adjuvant therapy for high-risk stage IA non-small cell lung cancer patients can significantly reduce recurrence rates and extend survival [2] - This finding provides new evidence for personalized treatment approaches in early lung cancer patients, potentially changing clinical practices [2] Group 2 - The conference features renowned thoracic surgery and thoracic oncology experts from Italy, the USA, Switzerland, Spain, Japan, and China, discussing core diseases such as lung cancer, esophageal cancer, mediastinal tumors, chest wall diseases, and lung transplantation [3] - Topics include innovations in minimally invasive surgical techniques, perioperative comprehensive treatment (especially the application of targeted and immunotherapy), key techniques in lung transplantation, rapid recovery concepts, and the role of artificial intelligence in predicting postoperative complications and aiding clinical decision-making [3] - The conference also released the "Guidelines for Interventional Pulmonology," covering various fields including diagnosis and treatment, aimed at enhancing surgical techniques for physicians [3]
2025北京国际胸外科学术大会召开
Yang Shi Wang· 2025-07-26 03:48
Core Insights - The "2025 Beijing International Thoracic Surgery Academic Conference" focuses on the latest technologies and challenges in thoracic surgery, aiming to create a high-level academic exchange platform for future development in the field [2] Group 1: Conference Highlights - The conference discusses core diseases such as lung cancer, esophageal cancer, mediastinal tumors, chest wall diseases, and lung transplantation, emphasizing innovations in minimally invasive surgical techniques and perioperative comprehensive treatments [2] - Key topics include the application of targeted therapy and immunotherapy, critical techniques in lung transplantation, donor assessment, rapid recovery concepts, and the role of artificial intelligence in predicting postoperative complications and aiding clinical decision-making [2] Group 2: Lung Cancer Statistics - According to 2022 epidemiological data, lung cancer remains the most prevalent malignant tumor, with approximately 1.06 million new cases, accounting for 22.0% of all malignant tumors, and it has the highest mortality rate [2] - Despite advancements in targeted and immunotherapy drugs extending survival for many advanced non-small cell lung cancer patients, recurrence and metastasis remain significant challenges, highlighting the importance of early detection, diagnosis, and treatment [2] Group 3: Research Findings - A retrospective study presented by Professor Zhang Yi indicates that 10-15% of patients with IA stage lung cancer experience recurrence despite being traditionally considered candidates for surgery without adjuvant therapy [3] - The study suggests that patients with specific high-risk factors who receive adjuvant therapy post-surgery can significantly reduce recurrence rates and extend survival, providing new evidence for personalized precision treatment in early lung cancer [4]